Canada Pension Plan Investment Board’s Theravance Biopharma TBPH Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$845K	Hold	49,700	–	–	﹤0.01%	1069
2026 Q1	$807K	Hold	49,700	–	–	﹤0.01%	1068
2025 Q4	$930K	Buy	+49,700	New	+$824K	﹤0.01%	1093
2022 Q4	–	Sell	-9,500	Closed	-$96K	–	1258
2022 Q3	$96K	Hold	9,500	–	–	﹤0.01%	1085
2022 Q2	$86K	Hold	9,500	–	–	﹤0.01%	1152
2022 Q1	$91K	Hold	9,500	–	–	﹤0.01%	1188
2021 Q4	$105K	Hold	9,500	–	–	﹤0.01%	1331
2021 Q3	$70K	Hold	9,500	–	–	﹤0.01%	1287
2021 Q2	$138K	Hold	9,500	–	–	﹤0.01%	994
2021 Q1	$194K	Hold	9,500	–	–	﹤0.01%	1157
2020 Q4	$169K	Hold	9,500	–	–	﹤0.01%	1223
2020 Q3	$140K	Sell	9,500 -108,500	-92%	-$2.03M	﹤0.01%	953
2020 Q2	$2.48M	Buy	+118,000	New	+$3.03M	0.01%	675

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Canada Pension Plan Investment Board's TBPH Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 49,700 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Canada Pension Plan Investment Board first reported a position in TBPH in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.48M in Q2 2020. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Canada Pension Plan Investment Board held 49,700 shares of Theravance Biopharma worth $845K as of Q2 2026.
Canada Pension Plan Investment Board left its Theravance Biopharma share count unchanged in Q2 2026.
Theravance Biopharma made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1069 holding.
Canada Pension Plan Investment Board first reported a position in Theravance Biopharma in Q2 2020 and has held it in 13 quarters since.
Canada Pension Plan Investment Board's Theravance Biopharma position peaked at $2.48M in Q2 2020.
180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.